We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Research · July 14, 2020

Primary Tumor Characteristics and NGS Mutations as Biomarkers for Melanoma Immunotherapy Response

Pigment Cell & Melanoma Research

 

Additional Info

Pigment Cell & Melanoma Research
Primary Tumor Characteristics and Next Generation Sequencing Mutations as Biomarkers for Melanoma Immunotherapy Response
Pigment Cell Melanoma Res 2020 Jun 21;[EPub Ahead of Print], K Loo, G Gauvin, I Soliman, M Renzetti, M Deng, E Ross, B Luo, H Wu, S Reddy, AJ Olszanski, JM Farma

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading